Cardiovascular Research Center, Consejo Superior de Investigaciones Científicas- Institut Català de Ciències Cardiovasculars, Hospital de Santa Creu i Sant Pau (Universitat Autonoma de Barcelona), Barcelona, Spain.
Arterioscler Thromb Vasc Biol. 2010 Jun;30(6):1246-52. doi: 10.1161/ATVBAHA.110.205112. Epub 2010 Apr 1.
To investigate the effect of rosuvastatin on platelet deposition under controlled shear rate conditions and to identify new platelet proteins involved in the interaction with the activating substrate.
Platelet-vessel wall interaction and thrombosis take place under dynamic conditions involving the interaction of the exposed damaged vascular wall with the circulating blood cells and proteins. Blood was perfused over type I collagen at different wall shear rates, and platelet deposition was measured by confocal microscopy. Perfused effluent blood was collected, platelets were sequentially extracted based on differential protein solubility, and proteins were separated by 2D gel electrophoresis. Blockade of 3-hydroxy-3-methylglutaryl-coenzyme A reductase significantly reduced platelet deposition and modulated the expression pattern of 18 proteins in the platelet subproteome. Among them, an increase in platelet surface 78-kDa glucose-regulated protein (GRP78), a stress-inducible multifunctional endoplasmic reticulum protein, was clearly apparent. Immunoprecipitation of platelet GRP78 revealed its interaction with tissue factor. Moreover, blockade of surface GRP78 resulted in a substantial increase in platelet deposition and tissue factor procoagulant activity and in a decrease in clotting time.
These findings demonstrate that blockade of 3-hydroxy-3-methylglutaryl-coenzyme A reductase reduces platelet deposition and inhibits GRP78 translocation from the platelet surface after shear and collagen activation. For the first time to our knowledge, this study reports on the presence and functional role of GRP78 in platelets and indicates that GRP78 has additional functions beyond those of a molecular chaperone.
研究在控制切变率条件下瑞舒伐他汀对血小板沉积的影响,并鉴定与激活底物相互作用的新血小板蛋白。
血小板-血管壁相互作用和血栓形成发生在涉及暴露的受损血管壁与循环血细胞和蛋白质相互作用的动态条件下。血液在不同壁切变率下流过 I 型胶原,通过共聚焦显微镜测量血小板沉积。收集灌注流出的血液,根据差异蛋白溶解度依次提取血小板,并通过 2D 凝胶电泳分离蛋白质。3-羟基-3-甲基戊二酰辅酶 A 还原酶的阻断显著减少了血小板沉积,并调节了血小板亚蛋白组中 18 种蛋白质的表达模式。其中,血小板表面 78kDa 葡萄糖调节蛋白(GRP78)的增加明显,GRP78 是一种应激诱导的多功能内质网蛋白。血小板 GRP78 的免疫沉淀显示其与组织因子相互作用。此外,表面 GRP78 的阻断导致血小板沉积和组织因子促凝活性显著增加,凝血时间缩短。
这些发现表明,3-羟基-3-甲基戊二酰辅酶 A 还原酶的阻断减少了血小板沉积,并抑制了剪切和胶原激活后 GRP78 从血小板表面的易位。据我们所知,这项研究首次报道了 GRP78 存在于血小板中及其功能作用,并表明 GRP78 除了分子伴侣的作用之外,还具有其他功能。